Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, HT, see Serotonin

Size: px
Start display at page:

Download "Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin"

Transcription

1 A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, Acinic cell carcinoma of pancreas, vs ductal adenocarcinoma, vs islet cell tumor, Adenomatoid tumor vs hemangioma, 200 Adrenocortical carcinoma vs hepatocellular carcinoma, Adrenocortical tumor vs metastatic carcinoma, vs pheochromocytoma, vs renal cell carcinoma, , ALK, for pseudosarcomas, 240 Alphafetoprotein, for embryonal carcinoma, 252 AMACR (p504s), for prostatic glandular hyperplasia, prostatic adenocarcinoma, Amylase, for acinic cell tumor, Angiomyolipoma vs sarcomatoid renal carcinoma, Angiosarcoma vs lymphangiosarcoma, B Basal cell carcinoma vs merkel cell carcinoma, BCL2, for synovial sarcoma, undifferentiated nasopharyngeal carcinoma, Benign glandular hyperplasia vs adenocarcinoma of uterine cervix, BetaHCG, for embryonal carcinoma, 252 Biphasic mesothelioma vs synovial sarcoma, Bowen disease vs Paget disease, vs in situ melanoma, Breast carcinoma vs adenocarcinoma of lung,

2 C CA-125, for metastatic ovarian carcinoma, Calcitonin, for thyroid medullary carcinoma, Calretinin, for adenomatoid tumor, biphasic mesothelioma, cystic mesothelioma, malignant mesothelioma, peritoneal mesothelioma, reactive mesothelium, sarcomatoid mesothelioma, sex cord stromal tumor, Carcinoma of lung with clear cells, CD1a, for Langerhans cell histiocytosis, CD3, for lymphoma, , thymoma, CD10, for endometrial stromal sarcoma, CD15, for Hodgkin lymphoma, CD20, for gastrointestinal tract lymphoma, large cell lymphoma, lymphoma, , CD30, for embryonal carcinoma, lymphoma, CD31, for angiosarcoma, 46-47, 52-57, epithelioid angiosarcoma, 52-57, hemangioma, Kaposi sarcoma, lymphangioma, lymphangiosarcoma, CD34, for dermatofibrosarcoma, gastrointestinal stromal tumor, solitary fibrous tumor, CD45, for gastrointestinal tract lymphoma, large cell lymphoma, 12-15, lymphocytic infiltrate, CD68, for histiocytic skin reactions, CD99 (MIC2), for Ewing/PNET, 22-23, 26-29, synovial sarcoma, 40-41,

3 CD117 (Kit), for gastrointestinal stromal tumor (58-59) mast cell disease, CEA, for adenocarcinoma of lung, , gastrointestinal tract carcinoma, gastrointestinal tract carcinoid, lung carcinoma, metastatic, pancreatic ductal cell carcinoma, thyroid medullary carcinoma, urothelial carcinoma, , Cholangiocarcinoma vs colonic adenocarcinoma, metastatic, vs hepatocellular carcinoma, Chondrosarcoma, vs chordoma, Chordoma vs chondrosarcoma, Chromogranin, for desmoplastic small cell tumor, gastrointestinal tract carcinoid, goblet cell carcinoid, islet cell tumor, neuroendocrine carcinoma, metastatic, 100 olfactory neuroblastoma, pheochromocytoma, , small cell carcinoma, , , CK7, for adenocarcinoma, metastatic, of lung, of ovary, cholangiocarcinoma, ovarian carcinoma, Paget disease, CK20, for adenocarcinoma of appendix, colonic adenocarcinoma, 70-71, , , colonic carcinoma, metastatic, 90-93, goblet cell carcinoid, merkel cell carcinoma, urothelial carcinoma, Cystic mesothelioma vs lymphangioma, Cytokeratin-positive angiosarcoma vs poorly differentiated carcinoma, 55 Cytokeratin, for acantholytic squamous cell carcinoma, adenomatoid tumor, basaloid carcinoma,

4 biphasic mesothelioma, Bowen's disease, chordoma, desmoplastic mesothelioma, desmoplastic small cell tumor, embryonal carcinoma, epithelioid agiosarcoma, 52-57, large cell carcinoma, 2-11 lobular carcinoma, metastatic, lymphoepithelial lesion, metastatic carcinoma, , , nasopharyngeal carcinoma, undifferentiated, ovarian epithelial tumor, poorly differentiated carcinoma, 52-57, 64-67, renal cell carcinoma, sarcomatoid mesothelioma, sarcomatoid renal carcinoma, signet ring cell carcinoma, small cell carcinoma, 22-25, , , , spindle cell carcinoma, squamous cell carcinoma, , synovial sarcoma, 40-41, thymoma, undifferentiated nasopharyngeal carcinoma, D D2-40, for lymphangiosarcoma, 46-47, Dermal fibrous scar vs desmoplastic melanoma, Dermatofibroma vs dermatofibrosarcoma, Dermatofibrosarcoma vs dermatofibroma, Dermatofibrosarcoma protuberans, 275 Desmoplastic melanoma vs dermal fibrous scar, Desmoplastic mesothelioma vs solitary fibrous scar, Desmoplastic small cell tumor vs other small cell tumors, Ductal adenocarcinoma of pancreas vs acinic cell carcinoma, Ductal adenosis vs tubular carcinoma of the breast, Ductal carcinoma of breast vs lobular carcinoma of breast, vs medullary carcinoma of breast,

5 E E-cadherin, for lobular carcinoma of breast, ductal carcinoma of breast, EMA (Epithelial membrane antigen), for chordoma, meningioma, metastatic carcinoma, Paget disease, renal cell carcinoma, 94-97, sarcomatoid renal carcinoma, synovial sarcoma, Embryonal carcinoma vs testicular seminoma, Endometrial stromal sarcoma vs uterine leiomyosarcoma, Epithelioid angiosarcoma vs poorly differentiated carcinoma, Epithelioid gastrointestinal stromal tumor vs metastatic carcinoma, Estrogen receptor (ER), for adenocarcinoma of endometrium, breast carcinoma, metastatic, 74-75, , ductal carcinoma of breast, endometrial stromal sarcoma, ovarian carcinoma, metastatic, 70-71, uterine leiomyosarcoma, Ewing/PNET vs rhabdomyosarcoma, vs small cell carcinoma, 22-23, F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, HT, see Serotonin G Gastrointestinal stromal tumor vs leiomyosarcoma, Gastrointestinal tract lymphoma vs poorly differentiated carcinoma, Gastrointestinal tract carcinoid vs gastrointestinal tract carcinoma, Gastrointestinal tract carcinoma vs gastrointestinal tract carcinoid, GFAP (glial fibrillary acidic protein), for glioma, Glandular hyperplasia of prostate vs prostatic adenocarcinoma, Glioma vs metastatic carcinoma,

6 Glomus tumor, 289 Goblet cell carcinoid vs adenocarcinoma of appendix, Granular cell tumor vs histiocytic skin reactions, H HCA (hepatocellular antigen, HepPar1), for hepatocellular carcinoma, 84-89, HCD (H-Caldesmon), for angiomyolipoma, glomus tumor, leiomyosarcoma, 42-45, uterine leiomyosarcoma, Hepatocellular carcinoma adrenocortical carcinoma, cholangiocarcinoma, metastatic adenocarcinoma, renal cell carcinoma, Hemangioma vs adenomatoid tumor, Histiocytic skin reactions granular cell tumor, HMB-45, for angiolipoma, melanoma, 2-5 spindle cell melanoma, HLA-DR, for medullary carcinoma of breast, nasopharyngeal carcinoma, undifferentiated, HMWK (high molecular weight keratin), for ductal adenosis of breast, glandular hyperplasia of prostate, Hodgkin lymphoma vs thymoma, Hydatiform mole vs hydropic abortion, Hydropic abortion vs hydatiform mole, I In situ melanoma vs Bowen disease, Inflammatory pseudosarcoma vs metaplastic carcinoma, Inhibin, for adrenocortical carcinoma, 98-99, , sex cord stromal tumor, Intrathyroid parathyroid adenoma vs thyroid follicular neoplasm, Islet cell tumor vs acinic cell carcinoma,

7 K Ki-67, for dermatofibrosarcoma, KIT (CD117), for gastrointestinal stromal tumor, 58-63, 100, mast cell disease, seminoma, L Langerhans cell histiocytosis vs nonspecific histiocytic infiltrate, Large cell carcinoma vs large cell lymphoma, 6-9 vs melanoma, 2-5 vs seminoma, Large cell lymphoma vs malignant melanoma, Leiomyosarcoma vs gastrointestinal stromal tumor, vs neurogenic sarcoma, Lipase, for vs acinic cell carcinoma, Lobular carcinoma vs ductal carcinoma of breast, vs signet ring cell carcinoma, Lymphangioma vs cystic mesothelioma, Lymphangiosarcoma vs angiosarcoma, Lymphocytic infiltrate, Lymphoepithelial lesion vs malignant lymphoma, Lymphoma vs benign lymphocytic lesion, vs thymoma, M Melan-A, for melanoma, spindle cell melanoma, 32-33, Melanoma vs large cell lymphoma, 2-4, 6-8, vs seminoma, Medullary carcinoma vs ductal carcinoma of breast, Meningioma vs schwannoma, Merkel cell carcinoma vs basal cell carcinoma, vs small cell lung carcinoma,

8 Metaplastic carcinoma of bladder vs inflammatory pseudosarcoma, Metastatic tumors, see specific entities MIC2, see CD99 Microglandular hyperplasia of cervix, 213 MSA (muscle specific actin), for glomus tumor, Myeloid leukemic infiltrate vs malignant lymphoma, Myeloperoxidase vs myeloid leukemic infiltrate, vs malignant lymphoma, Myogenin, for rhabdomyosarcoma, N NB84, for neuroblastoma, Nerve sheath neoplasm vs neurogenic sarcoma, vs leiomyosarcoma, Neuroblastoma vs Wilms tumor, Neurogenic sarcoma vs leiomyosarcoma, vs spindle cell melanoma, Nonspecific histiocytic infiltrate vs Langerhans cell histiocytosis, NSE (neuronal enolase), for islet cell tumor, solid and papillary neoplasm, O Olfactory neuroblastoma vs small cell carcinoma, Ovarian carcinoma vs colonic carcinoma, metastatic, vs peritoneal mesothelioma, Ovarian epithelial tumor vs sex cord stromal tumor, P p16, for adenocarcinoma of endometrium, adenocarcinoma of uterine cervix, benign glandular hyperplasia, p57, for hydatiform mole, hydropic abortion,

9 p63, for adenocarcinoma of prostate, basaloid squamous cell carcinoma, benign glandular hyperplasia, breast tumor, ductal adenosis, metaplastic carcinoma, , lymphoepithelial lesion, sebaceous carcinoma, squamous cell carcinoma, transitional cell carcinoma, urothelial carcinoma, Paget disease vs Bowen disease, vs in situ melanoma, Pancreatic amylase, for acinic cell carcinoma, Parathyroid adenoma vs thyroid follicular carcinoma, PTH (parathyroid hormone), for parathyroid adenoma, PDGFR (platelet-derived growth factor receptor alpha), for gastrointestinal stromal tumor, Peritoneal mesothelioma vs ovarian carcinoma, Pheochromocytoma vs adrenocortical tumor, vs metastatic carcinoma, PLAP (placental alkaline phosphatase), for embryonal carcinoma, seminoma, 10-11, testicular seminoma, PNET, see Ewing/PNET Poorly differentiated carcinoma vs epithelioid hemangioendothelioma, vs large cell carcinoma, 3 Progesterone receptor, for meningioma, Prostatic adenocarcinoma vs colonic adenocarcinoma, vs glandular hyperplasia, vs urothelial carcinoma, PSA (prostate specific antigen), for prostatic adenocarcinoma, prostatic carcinoma, 100, R RCA (renal cell carcinoma antigen), for renal cell carcinoma, 94-97, , , Reactive mesothelium vs lung adenocarcinoma, Renal cell carcinoma vs adrenocortical carcinoma,

10 vs hepatocellular carcinoma, vs lung adenocarcinoma, vs thyroid clear cell carcinoma, vs urothelial carcinoma, Rhabdomyosarcoma vs Ewing/PNET, vs small cell carcinoma, rosebud 323 S S100, for desmoplastic melanoma, granular cell tumor, in situ melanoma, Langerhans cell histiocytosis, melanoma, 2-5, 12-13, 14-15, 100, nerve sheath neoplasm, neurogenic sarcoma, spindle cell melanoma, Sarcomatoid mesothelioma vs synovial sarcoma of pleura, Sarcomatoid renal carcinoma vs angiomyolipoma, Schwannoma vs meningioma, Sebaceous carcinoma vs squamous cell carcinoma, Seminoma of mediastinum, 19 vs large cell carcinoma, vs melanoma, Serotonin (5-HT), for adenocarcinoma of appendix, gastrointestinal tract carcinoid, goblet cell carcinoma, Sertoli-Leydig cell tumor, 223 Signet ring cell carcinoma vs lobular carcinoma of breast, metastatic, Small cell carcinoma vs basaloid squamous cell carcinoma, vs Ewing/PNET, vs lymphocytic infiltrate, vs olfactory neuroblastoma, vs rhabdomysarcoma, Small cell tumors vs desmoplastic small cell tumor, Solitary fibrous tumor vs desmoplastic mesothelioma, Spindle cell carcinoma vs spindle cell melanoma, 30-31, vs spindle cell sarcoma, vs synovial sarcoma,

11 Spindle cell melanoma vs spindle cell carcinoma, vs neurogenic sarcoma, Spindle cell sarcoma vs spindle cell carcinoma, Squamous cell carcinoma acantholytic type, 283 basaloid type, vs nasopharyngeal carcinoma, undifferentiated, vs sebaceous carcinoma, vs small cell lung carcinoma, Stromal sarcoma of uterus, 207 Synaptophysin (SP), for adrenocortical tumor, gastrointestinal tract carcinoid, olfactory neuroblastoma, pheochromocytoma, small cell carcinoma, 100, Synovial sarcoma vs biphasic mesothelioma, vs sarcomatoid mesothelioma, vs spindle cell carcinoma, T Testicular seminoma vs embryonal carcinoma, T-F (Thomsen-Friedenreich) antigen, for sebaceous carcinoma, TGB (thyroglobulin), for thyroid carcinoma, ; metastatic, thyroid clear cell carcinoma, thyroid follicular carcinoma, thyroid follicular neoplasm, Thymoma vs Hodgkin lymphoma, vs lymphoma, Thyroid carcinoma, vs renal cell carcinoma, metastatic, Thyroid clear cell carcinoma vs renal cell carcinoma, metastatic, Thyroid follicular carcinoma vs thyroid medullary carcinoma, Thyroid follicular neoplasm vs intrathyroid parathyroid adenoma, Thyroid medullary carcinoma vs thyroid follicular carcinoma, TTF-1 (thyroid transcription factor), for adenocarcinoma of lung, , , , ; metastatic, 100, 152 small cell carcinoma, ; of lung, ; metastatic, 100,

12 thyroid clear cell carcinoma, thyroid follicular carcinoma, thyroid medullary carcinoma, Trypsin, for acinic cell tumor, Tryptase, Tubular carcinoma of breast vs ductal adenosis of breast, Tyrosinase, for spindle cell melanoma, U Unclassifiable myxoid sarcoma, 39 Undifferentiated nasopharyngeal carcinoma vs squamous cell carcinoma, Uroplankin, for urothelial carcinoma, Urothelial carcinoma vs prostatic adenocarcinoma, Uterine leiomyosarcoma vs endometrial stromal sarcoma, V vwf, for angiosarcoma, 46-47, epithelioid hemangioendothelioma, Kaposi sarcoma, lymphangiosarcoma, W Wilms tumor vs neuroblastoma, WT-1, for Wilms tumor,

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background

More information

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1 Stony Brook BioBank Specimen Collection (updated 2//6) Site Diagnosis Cardiovascular System 659 Heart: Atrial myxoma Artery: 5 Normal 5 Blood: 652 Vein: Leiomyosarcoma well-differentiated (inferior vena

More information

A23: Oncologic Disease- Tumor Markers

A23: Oncologic Disease- Tumor Markers A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of

More information

The develpemental origin of mesothelium

The develpemental origin of mesothelium Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal

More information

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer

More information

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Table of Contents Page Undifferentiated panel 1 CK7/20 table 2 Breast carcinoma

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

Ovarian tumors Ancillary methods

Ovarian tumors Ancillary methods Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of

More information

Practical Effusion Cytology

Practical Effusion Cytology Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.

More information

Lessons from a consultation practice

Lessons from a consultation practice Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter

More information

The term undifferentiated tumor has been used in reference

The term undifferentiated tumor has been used in reference Undifferentiated Tumor True Identity by Immunohistochemistry Armita Bahrami, MD; Luan D. Truong, MD; Jae Y. Ro, MD, PhD Context. Undifferentiated tumor refers to a heterogeneous group of neoplasms with

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion. Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case

More information

Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls

Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls Aus dem Institut für Pathologie der Medizinischen Fakultät Charité Universitätsmedizin Berlin DISSERTATION Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls

More information

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1 Immunohistochemistry of clear cell tumours J. Klos MD Department of Pathology Stavanger University Hospital Norway What are clear cell tumours? Multiple factors in etiology of clear cell changes: - technical

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP2003R1 http://hkcpath.org. Correspondence: pkhui@ha.org.hk 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from

More information

OCCULT PRIMARY CANCER

OCCULT PRIMARY CANCER OCCULT PRIMARY CANCER พญ.ครองกมล ส หบ ณฑ หน วยมะเร งว ทยา INTRODUCTION Occult primary cancers or cancer of unknown primary (CUPS) Histologically proven metastatic malignant tumors whose primary site cannot

More information

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron

More information

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of

More information

Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion

Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic

More information

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Rodney T. Miller, M.D. Director of Immunohistochemistry ProPath Laboratory 1355 River Bend Drive Dallas, TX 75247-4915

More information

Cytopreparation, Instrumentation, and Automated Screening in Gynecologic Cytology

Cytopreparation, Instrumentation, and Automated Screening in Gynecologic Cytology Table of Contents PART 1: GYNECOLOGIC CYTOPATHOLOGY SECTION I: OVERVIEW Pap Test: History and Reporting Terminology Cytopreparation, Instrumentation, and Automated Screening in Gynecologic Cytology Specimen

More information

Effusions: Mesothelioma and Metastatic Cancers

Effusions: Mesothelioma and Metastatic Cancers Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,

More information

Abstracts and References

Abstracts and References Abstracts and References Soft Tissue Pathology Professor Cyril Fisher, Royal Marsden Hospital Learning points CD34 and CK positivity coexist in epithelioid sarcoma and epithelioid endothelial tumours.

More information

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9)

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) New IHC Antibodies 2 Table of Contents page antibody 1 2 3 4 5 6 7 8 Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) Caveolin-1 (2297) CD13 (SP187) CD16 (SP175)

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University College London, operating UK NEQS for ccredited to UK NEQS ICC & ISH

More information

Determination of the type and origin of metastatic

Determination of the type and origin of metastatic Diagnosis of Metastatic Neoplasms An Immunohistochemical Approach Murli Krishna, MD N Context. It is important to determine the type and/or site of origin of metastatic tumors for optimal clinical management.

More information

Histolab Products AB. Eva Alströmer Jonas Falgén. Helsingborg 7-8/10 2010

Histolab Products AB. Eva Alströmer Jonas Falgén. Helsingborg 7-8/10 2010 Histolab Products AB Eva Alströmer Jonas Falgén Helsingborg 7-8/10 2010 Table 1 Formalin Fixation Times and Estrogen Receptor Staining With 25 Minutes Antigen Retrieval Pretreatment Formalin Q-Score Difference

More information

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern Common Morphologic Patterns in Soft Tissue Tumors John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology The Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.

FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D. Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters:

More information

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd. Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell

More information

FNA cytology of lymphomas: useless or useful? Edneia Tani

FNA cytology of lymphomas: useless or useful? Edneia Tani FNA cytology of lymphomas: useless or useful? Edneia Tani Karolinska University Hospital Stockholm Sweden FNAC LYMPH NODE First report: FNAC LYMPH NODE Pioneers Sixten Franzén Lopez Cardoso FNAC LYMPH

More information

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short

More information

- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa

- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa - Slide Seminar - Endocrine pathology in non-endocrine organs Case 11 Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa Dept. of Pathology, Multimedica, Milan, Italy Dept. of Surgical and Morphological

More information

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter.

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. FRCPath Part 2 Histopathology Examination Histology short cases Commentary. Case 1. History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. Diagnosis: Angiomyolipoma

More information

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have

More information

FRCPath Part 2 Histopathology Short Cases, autumn 2014

FRCPath Part 2 Histopathology Short Cases, autumn 2014 FRCPath Part 2 Histopathology Short Cases, autumn 2014 Commentary Case 1 Female age 52: palpable lesion, left breast Breast, fat necrosis. Average: 2.6/5 This case was chosen as a good example of fat necrosis

More information

CatalogNo Product Name Size

CatalogNo Product Name Size SIG-3250-1000 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) SIG-3250-16 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) L1 6mL SIG-3250-26 α-1-antichymotrypsin Polyclonal Antibody,

More information

INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS

INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS INDEX SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS Performance Improvement Program in Surgical Pathology PIP CASE SUMMARY INDEX 1989-2012 Breast 89-17 Angiosarcoma 86% 89-37 Tubular adenoma 97%

More information

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.

More information

Immunohistochemistry (IHC) Outreach Services

Immunohistochemistry (IHC) Outreach Services Immunohistochemistry (IHC) Outreach Services Note t ype of fixative used if not neutral buffered f ormalin. Note t ype of tissue/specim en Unless specified otherwise, positive and negative controls react

More information

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH13-3603 N LB 13-0691 ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL BIOBANK LE-NIE HEST

More information

SIGNIFICANCE OF IMMUNOHISTOCHEMISTRY IN ACCURATE CHARACTERIZATION OF MALIGNANT TUMORS

SIGNIFICANCE OF IMMUNOHISTOCHEMISTRY IN ACCURATE CHARACTERIZATION OF MALIGNANT TUMORS SIGNIFICANCE OF IMMUNOHISTOCHEMISTRY IN ACCURATE CHARACTERIZATION OF MALIGNANT TUMORS Zubair Ahmed, Najamul Sahar Azad, Yasmeen Bhurgari, Rashida Ahmed, Naila Kayani, Shahid Pervez, Sheema Hasan Department

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Immunohistochemical classification of the unknown primary tumour

Immunohistochemical classification of the unknown primary tumour Immunohistochemical classification of the unknown primary tumour NordiQC Workshop 2014 Prof. Mogens Vyberg Institute of Pathology Aalborg, Denmark PART 2 Secondary panels for carcinoma identification/subclassification

More information

Histopathology of Major Salivary Gland Neoplasms

Histopathology of Major Salivary Gland Neoplasms Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department

More information

Utility of immunohistochemistry in the diagnosis of bone tumors

Utility of immunohistochemistry in the diagnosis of bone tumors Dr. M. Sailaja Review article Utility of immunohistochemistry in the diagnosis of bone tumors Sailaja M 1,* and Satish Rao I 1 1 Department of Laboratory Medicine, Krishna Institute of Medical sciences,

More information

Pathology of the Female Peritoneum, Common and Uncommon Problems

Pathology of the Female Peritoneum, Common and Uncommon Problems Pathology of the Female Peritoneum, Common and Uncommon Problems An Update on Gynecologic Pathology Florence, Italy Anaís Malpica, M.D. Professor of Pathology Pathology of the Female Peritoneum Keratin

More information

Cytokeratins and generel epithelial markers in tumour classification

Cytokeratins and generel epithelial markers in tumour classification Cytokeratins and generel epithelial markers in tumour classification 42, liver adenocarcinoma of unknown primary Colonrectum? Pancreas/biliary tract? Stomach? Lung? Ovary/endometrium? Mogens Vyberg, NordiQC

More information

CAP Companion Meeting at USCAP 2007 PATHOLOGIC EVALUATION OF MALIGNANT NEOPLASMS WITH INDETERMINATE MORPHOLOGICAL CHARACTERISTICS

CAP Companion Meeting at USCAP 2007 PATHOLOGIC EVALUATION OF MALIGNANT NEOPLASMS WITH INDETERMINATE MORPHOLOGICAL CHARACTERISTICS CAP Companion Meeting at USCAP 2007 PATHOLOGIC EVALUATION OF MALIGNANT NEOPLASMS WITH INDETERMINATE MORPHOLOGICAL CHARACTERISTICS Profess of Pathology University of Virginia Medical Center Room 3020 University

More information

The menstrual cycle Hypophysis

The menstrual cycle Hypophysis Normal endometrium Tumors of the uterine corpus by MB The endometrium comprises the zona functionalis zf (superficial two thirds) ) and the zona basalis zb (deep one third) The zf responds to hormonal

More information

Notice of Faculty Disclosure

Notice of Faculty Disclosure The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with

More information

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia

More information

An Introduction to Cancer and Basic Cancer Vocabulary

An Introduction to Cancer and Basic Cancer Vocabulary An Introduction to Cancer and Basic Cancer Vocabulary Marc B. Garnick, MD Beth Israel Deaconess Medical Center Harvard Medical School, Boston Medical Director Cancer Programs Northeast Hospital Corporation,

More information

3-F. Pathology of Mesothelioma

3-F. Pathology of Mesothelioma 3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce

More information

Thyroid Transcription Factor-1 (TTF 1): protein expression is not exclusive to lung and thyroid tissue.

Thyroid Transcription Factor-1 (TTF 1): protein expression is not exclusive to lung and thyroid tissue. Thyroid Transcription Factor-1 (TTF 1): protein expression is not exclusive to lung and thyroid tissue. Scorer PW, Pinkney M, McIntosh GG. Leica Biosystems Newcastle Ltd, Balliol Business Park West, Benton

More information

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Anatomic Pathology / TTF-1 IN CYTOLOGY OF BODY FLUIDS The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Jonathan L. Hecht, MD,

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors

Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors Available online at www.sciencedirect.com Annals of Diagnostic Pathology 12 (2008) 72 84 Review Article Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors Mark R. Wick,

More information

Pathology Update THE ROLE OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF SOFT-TISSUE TUMORS

Pathology Update THE ROLE OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF SOFT-TISSUE TUMORS Pathology Update THE ROLE OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF SOFT-TISSUE TUMORS Carlos A. Muro-Cacho, MD, PhD Pathology Service, H. Lee Moffitt Cancer Center & Research Institute

More information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital

More information

TUMOR MARKERS TUMOR MARKERS

TUMOR MARKERS TUMOR MARKERS TUMOR MARKERS TUMOR MARKERS From dreams An ideal tumor maker (TM) would be a substance produced only by the neoplasic cells, specific to one type of tumor (no false positives) and detectable right from

More information

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids Cytology of Effusion Fluids John W. Wong, MD, FRCPC Sunnybrook Health Sciences Centre Assistant Professor, Laboratory Medicine and Pathobiology Faculty of Medicine, University of Toronto November 10, 2012

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

Problem Cases in Surgical Pathology XXV Congreso de la Sociedad Española de Patologia (SEAP) - Zaragoza, Mayo 18-21, 2011.

Problem Cases in Surgical Pathology XXV Congreso de la Sociedad Española de Patologia (SEAP) - Zaragoza, Mayo 18-21, 2011. Problem Cases in Surgical Pathology XXV Congreso de la Sociedad Española de Patologia (SEAP) - Zaragoza, Mayo 18-21, 2011. Saul Suster, M.D. Medical College of Wisconsin Milwaukee, WI, USA Case - 2 Clinical

More information

INDEX. in this web service Cambridge University Press. References to Figures are in bold.

INDEX. in this web service Cambridge University Press. References to Figures are in bold. References to Figures are in bold. AAH (atypical adenomatous hyperplasia) 124 125 abscesses 33, 35 amebic 48 ACC (adenoid cystic carcinoma) 179, 179 180, 180, 181 acinar adenocarcinoma 126 127 moderately

More information

IMMUNOHISTOCHEMICAL APPROACHES TO THE DIAGNOSIS OF UNDIFFERENTIATED MALIGNANT TUMORS

IMMUNOHISTOCHEMICAL APPROACHES TO THE DIAGNOSIS OF UNDIFFERENTIATED MALIGNANT TUMORS IMMUNOHISTOCHEMICAL APPROACHES TO THE DIAGNOSIS OF UNDIFFERENTIATED MALIGNANT TUMORS Mark R. Wick, M.D. From the Division of Surgical Pathology & Cytopathology, University of Virginia Health System, Charlottesville,

More information

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information. 5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen

More information

A guide to cancer types and chemotherapy medications

A guide to cancer types and chemotherapy medications A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets

Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets Lung cancer data in the National Cancer Data Repository, Hospital Episode Statistics and National Lung Cancer Audit datasets A comparison of case ascertainment and recording of lung cancer histology and

More information

A Better Path for Cancer Diagnostics

A Better Path for Cancer Diagnostics INTERPRETATION FLEX Ready-to-Use Atlas of Stains - 4 th Edition A Better Path for Cancer Diagnostics Committed to raising the bar for higher quality During the last decades, organizations such as CAP,

More information

Immunohistology of the Mediastinum

Immunohistology of the Mediastinum Immunohistology of the Mediastinum Mark R. Wick 1 CHPTER OUTLINE Introduction 301 iology of antigens/antibodies 301 lgorithmic immunohistochemistry of mediastinal disease 302 Immunohistologic findings

More information

Pleural and Chest Wall Tumors

Pleural and Chest Wall Tumors Pleural and Chest Wall Tumors Ritu Gill, MD, MPH Dr. Ritu R. Gill Department t of Radiology Brigham and Women s Hospital Harvard Medical School CLASSIFICATION OF CHEST WALL TUMORS Primary neoplasm of chest

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help

More information

A 70-year old Man with Pleural Effusion

A 70-year old Man with Pleural Effusion Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which

More information

Immunostain Update: Diagnosis of Metastatic Breast Carcinoma, Emphasizing the Distinction from Gynecologic Cancers

Immunostain Update: Diagnosis of Metastatic Breast Carcinoma, Emphasizing the Distinction from Gynecologic Cancers Immunostain Update: Diagnosis of Metastatic Breast Carcinoma, Emphasizing the Distinction from Gynecologic Cancers Yunn-Yi Chen, M.D., Ph.D. UCSF Pathology Department yunn-yi.chen@ucsf.edu June 3, 2010

More information

Case of the. Month October, 2012

Case of the. Month October, 2012 Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix

More information

190.25 - Alpha-fetoprotein

190.25 - Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Diagnostic Challenge. Department of Pathology,

Diagnostic Challenge. Department of Pathology, Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital

More information

immunohistochemistry stain offerings

immunohistochemistry stain offerings immunohistochemistry stain offerings TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS. www.aruplab.com/ap-ihc JULY 2015 Information in this brochure is current as of July 2015. All content is subject to change.

More information

Case presentation. Awatif Al-Nafussi

Case presentation. Awatif Al-Nafussi Case presentation Awatif Al-Nafussi Case History 49 year old DVT & small PE June 08, Pelvic mass Ca125 33 Laparotomy-TAHBSO, drainage of ascites Ovarian carcinoma Clinical diagnosis Multiple specimens

More information